Detalhe da pesquisa
1.
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy.
Kidney Int
; 105(1): 189-199, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914086
2.
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy.
Kidney Int
; 105(6): 1306-1315, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552841
3.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Lancet
; 402(10417): 2077-2090, 2023 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931634
4.
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD.
J Am Soc Nephrol
; 34(6): 955-968, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918388
5.
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression.
J Am Soc Nephrol
; 33(2): 291-303, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862238
6.
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis.
Am J Kidney Dis
; 78(3): 340-349.e1, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33775708
7.
Hypouricaemia in a patient with hereditary xanthinuria type I.
Lancet
; 403(10435): 1493, 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38614487
8.
Observational study on the incidence of nephrogenic systemic fibrosis in patients with renal impairment following gadoterate meglumine administration: the NSsaFe study.
J Magn Reson Imaging
; 51(2): 607-614, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31287213
9.
Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.
J Am Soc Nephrol
; 30(9): 1756-1769, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292198
10.
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.
Lancet
; 389(10084): 2117-2127, 2017 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28363480
11.
Hereditary polycystic kidney disease is characterized by lymphopenia across all stages of kidney dysfunction: an observational study.
Nephrol Dial Transplant
; 33(3): 489-496, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28387829
12.
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis.
Am J Kidney Dis
; 68(3): 392-401, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27032886
13.
A Multifocal Abdominal Mass in a Renal Transplant Recipient.
Gastroenterology
; 152(8): 1834-1835, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28478150
14.
Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study).
Eur Radiol
; 23(5): 1250-9, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23212275
15.
RSV induced rhabdomyolysis: a case report.
Acta Clin Belg
; 78(4): 313-315, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36065975
16.
Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study.
Kidney Int Rep
; 8(5): 968-979, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37180505
17.
Clinicopathological characteristics and disease chronicity in native kidney biopsies in Flanders.
Clin Kidney J
; 16(1): 125-137, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36726429
18.
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD.
Clin J Am Soc Nephrol
; 18(2): 183-192, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754007
19.
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure.
Nat Med
; 29(7): 1867-1876, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37330614
20.
Epidemiology of native kidney disease in Flanders: results from the FCGG kidney biopsy registry.
Clin Kidney J
; 15(7): 1361-1372, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35756729